The Latest Cardiac and Vascular News
SANTA CRUZ, Calif.–(BUSINESS WIRE)– Murj, Inc., a healthcare technology company focused on transforming implantable cardiac device management, today announced the availability of OnSite™— the industry’s first cloud-based workflow solution for in-office cardiac device management. OnSite is an extension of Murj’s proven workflow for remote transmission management. With today’s announcement, Murj […]
ABBOTT PARK, Ill., April 11, 2018 /PRNewswire/ — Abbott (NYSE: ABT) today announced the initiation of a clinical trial evaluating long-term outcomes of patients who undergo stent implantation guided by high-resolution light-based imaging technology—called optical coherence tomography (OCT)—compared to a common X-ray-guided technique called angiography. The trial (ILUMIEN IV) is the first large-scale randomized global […]
SOUTH JORDAN, Utah, April 11, 2018 (GLOBE NEWSWIRE) — Merit Medical Systems, Inc. (NASDAQ:MMSI), a leading manufacturer and marketer of proprietary disposable devices used in interventional, diagnostic and therapeutic procedures, particularly in cardiology, radiology, oncology, critical care and endoscopy, announced today that it will release its financial results for the […]
PLYMOUTH, Minn.–(BUSINESS WIRE)–Interrad Medical, a privately held medical device company, announces the SecurAcath Subcutaneous Catheter Securement Device has been selected for the Innovation and Technology Payment (ITP) Program by the National Health Service (NHS) England. The ITP Program is designed to remove significant barriers to the spread and adoption of […]
REDWOOD CITY, Calif.–(BUSINESS WIRE)–HeartFlow, Inc. today announced that NHS England has chosen the HeartFlow® FFRct Analysis as part of the Innovation and Technology Payment (ITP) program. The HeartFlow Analysis was chosen as a new technology to be funded by ITP through a competitive process of nearly 300 applicants. It is the only ITP […]
IRVINE, Calif.–(BUSINESS WIRE)–JenaValve Technology, Inc., a developer, manufacturer and marketer of differentiated transcatheter aortic valve replacement (TAVR) systems for the treatment of aortic valve disease, today announced successful patient enrollment in the CE Mark study of the next generation JenaValve Pericardial TAVR System utilizing the Coronatix™ Transfemoral Delivery Catheter for […]
SOUTHLAKE, Texas – ( BUSINESS WIRE ) – HeartSciences , a medical device company that is at the forefront of innovation in the field of electrocardiography thanks to the application of artificial intelligence and signal processing based on continuous waveforms (continuous wavelet transform, CWT), today announced the results of a clinical study conducted serially […]
WASHINGTON, April 9, 2018 /PRNewswire/ — An article published in Experimental Biology and Medicine (Volume 243, Issue 7, April, 2018) reports that supporting cells in the heart, known as fibroblasts, are selectively activated by factors present in heart disease. The study, led by Dr. Megan McCain, Assistant Professor in the Department of Biomedical Engineering and Department […]
PETAH TIKVA, Israel, April 10, 2018 /PRNewswire/ — Leviticus Cardio, the inventor of wireless power transfer for Left Ventricular Assisted Devices, or “LVADs”, for patients with severe cardiac issues, has announced another round of successful animal trials, well beyond periods required to demonstrate suitability for chronic conditions. The company confirms that the successful studies […]
DUBLIN, April 10, 2018 /PRNewswire/ — The “Interventional Cardiology and Peripheral Vascular Device Market Report: Trends, Forecast and Competitive Analysis”report has been added to ResearchAndMarkets.com’s offering. The global interventional cardiology and peripheral vascular device market is expected to reach an estimated $26.3 billion by 2023, and it is forecast to grow at a CAGR of 5.5% from […]
